Envestnet Asset Management’s NewAmsterdam Pharma NAMS Stock Holding History

Envestnet Asset Management’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$526K	Sell	15,520 -30	-0.2%	-$989	﹤0.01%	4034
2026 Q1	$498K	Sell	15,550 -2,022	-12%	-$65.9K	﹤0.01%	3939
2025 Q4	$616K	Buy	+17,572	New	+$639K	﹤0.01%	3565
2025 Q1	–	Sell	-9,359	Closed	-$241K	–	4435
2024 Q4	$241K	Sell	9,359 -8,738	-48%	-$186K	﹤0.01%	4002
2024 Q3	$300K	Sell	18,097 -1,067	-6%	-$18.5K	﹤0.01%	3821
2024 Q2	$368K	Buy	19,164 +10,125	+112%	+$203K	﹤0.01%	3615
2024 Q1	$214K	Buy	+9,039	New	+$183K	﹤0.01%	3914

Other funds holding NAMS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Envestnet Asset Management's NAMS Position: Q2 2026 in Review

Envestnet Asset Management reduced its NewAmsterdam Pharma (NAMS) stake by 0.19% in Q2 2026, selling an estimated $989 and leaving 15,520 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #4034.

Envestnet Asset Management first reported a position in NAMS in Q1 2024 and has held it in 7 quarters since. The position peaked at $616K in Q4 2025. 195 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

Envestnet Asset Management held 15,520 shares of NewAmsterdam Pharma worth $526K as of Q2 2026.
Envestnet Asset Management sold 30 NewAmsterdam Pharma shares in Q2 2026, an estimated $989.
NewAmsterdam Pharma made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4034 holding.
Envestnet Asset Management first reported a position in NewAmsterdam Pharma in Q1 2024 and has held it in 7 quarters since.
Envestnet Asset Management's NewAmsterdam Pharma position peaked at $616K in Q4 2025.
195 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.